About James Hart, Jr.
Form D filings for RheumaGen from 2022 to 2024 list James Hart, Jr. as executive officer.
James Hart, Jr. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name James Hart, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Hart, Jr. works with at each company, as listed on that company's latest Form D.
RheumaGen, Inc. · Form D, Apr 17, 2024
RH
Ryan Hart
Chief Legal Officer
BM
Bobak Mozayeni
Executive officer
BG
Bruce Goodwin
Director
TF
Thomas Fratacci
Director
BF
Brian Freed
Executive officer
RI
Richard Freed, III
Executive officer and director